UBS Group
HSCS icon

UBS Group’s Heart Test Laboratories HSCS Stock Holding History

UBS Group’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.3K Buy
6,476
+508
+9% +$1.48K ﹤0.01% 8080
2025
Q4 		$18.4K Buy
+5,968
New +$17.7K ﹤0.01% 7843
2025
Q2 		– Sell
-2,625
Closed -$7.4K – 10510
2025
Q1 		$7.4K Buy
2,625
+1,320
+101% +$4.41K ﹤0.01% 8828
2024
Q4 		$4.99K Buy
1,305
+624
+92% +$2.14K ﹤0.01% 8705
2024
Q3 		$3.3K Sell
681
-5,715
-89% -$20.9K ﹤0.01% 8290
2024
Q2 		$33.3K Buy
+6,396
New +$50.8K ﹤0.01% 6996
2023
Q2 		– Sell
-11
Closed -$1.09K – 9208
2023
Q1 		$1.09K Sell
11
-9
-45% -$1.22K ﹤0.01% 8816
2022
Q4 		$1.64K Buy
20
+2
+11% +$313 ﹤0.01% 9822
2022
Q3 		$2K Sell
18
-25
-58% -$4.27K ﹤0.01% 9730
2022
Q2 		$8K Buy
+43
New +$8.31K ﹤0.01% 8308

Other funds holding HSCS

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
TA
TFB Advisors Overland Park, Kansas $191M AUM 18.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

UBS Group's HSCS Position: Q1 2026 in Review

UBS Group increased its Heart Test Laboratories (HSCS) stake by 8.5% in Q1 2026, buying an estimated $1.48K and bringing the position to 6,476 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #8080.

UBS Group first reported a position in HSCS in Q2 2022 and has held it in 10 quarters since. The position peaked at $33.3K in Q2 2024. 13 funds tracked by Wall St. Rank hold HSCS as of Q1 2026.

  • UBS Group held 6,476 shares of Heart Test Laboratories worth $16.3K as of Q1 2026.
  • UBS Group bought 508 Heart Test Laboratories shares in Q1 2026, an estimated $1.48K.
  • Heart Test Laboratories made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #8080 holding.
  • UBS Group first reported a position in Heart Test Laboratories in Q2 2022 and has held it in 10 quarters since.
  • UBS Group's Heart Test Laboratories position peaked at $33.3K in Q2 2024.
  • 13 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.